Nuclear Medicine: Page 52

More Mo-99 production woes at ANSTO

By AuntMinnie.com staff writers

A mechanical problem at the Australian Nuclear Science and Technology Organisation's (ANSTO) Lucas Heights nuclear medicine facility has again forced the medical isotope maker to curtail production.

September 12, 2019

PET, MRI link amyloid plaque with swift decline

By Wayne Forrest

Patients whose PET and MR images show beta-amyloid plaque accumulation in the brain experience a significantly faster path toward dementia than people with vascular dementia and no plaque deposits, according to a study published online September 11 in Neurology.

September 11, 2019

Ga-68 PSMA PET/MRI, mpMRI work for prostate cancer analysis

By Wayne Forrest

Prostate cancer patients at intermediate or high risk of advanced disease can benefit from either gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) PET/MRI or multiparametric MRI (mpMRI) alone to diagnose specific features of their disease, according to a study published September 10 in Radiology.

September 11, 2019

Digirad acquires modular housing firm

By AuntMinnie.com staff writers

Digirad is expanding its portfolio beyond nuclear medicine equipment and services with the acquisition of ATRM Holdings, a manufacturer of commercial and residential modular housing units.

September 10, 2019

Blue Earth touts talks at ASTRO 2019

By AuntMinnie.com staff writers

Bracco molecular imaging subsidiary Blue Earth Diagnostics is directing attention to several presentations at the upcoming annual meeting of the American Society for Radiation Oncology (ASTRO) later this week in Chicago.

September 10, 2019

ASNC releases directive on cardiac amyloidosis imaging

By AuntMinnie.com staff writers

The American Society of Nuclear Cardiology (ASNC) has published a set of recommendations for multimodality imaging of cardiac amyloidosis.

September 8, 2019

Imaging groups oppose cuts in myocardial PET rates

By AuntMinnie.com staff writers

A number of imaging organizations are voicing their opposition to proposed payment reductions related to myocardial PET equipment.

September 5, 2019

NaF-PET/CT does well in detecting prostate metastases

By Wayne Forrest

Nuclear medicine physicians showed high accuracy and consistency when reading sodium fluoride (NaF)-PET/CT scans of patients with prostate cancer metastases in a new study, published online September 3 in the Journal of Nuclear Medicine.

September 5, 2019

Northwest Medical scores Mo-99 funds

By AuntMinnie.com staff writers

Northwest Medical Isotopes will receive funding from the U.S. Department of Energy's National Nuclear Security Administration to support the production of molybdenum-99 (Mo-99) from low-enriched uranium.

September 3, 2019

Shine names VP of European operations

By AuntMinnie.com staff writers

Medical isotope firm Shine Medical Technologies has appointed Harrie Buurlage as vice president (VP) of European operations.

September 3, 2019

Curium changes pricing for Tc-99m product

By AuntMinnie.com staff writers

Nuclear medicine firm Curium Pharma has announced plans to implement a new pricing model for Technescan MAG3, a kit for preparing technetium-99m (Tc-99m) mertiatide.

September 3, 2019

Subtle Medical wins 1st clinical installation for SubtlePET

By AuntMinnie.com staff writers

Imaging artificial intelligence (AI) software developer Subtle Medical's SubtlePET AI algorithm has been placed into clinical use at Hoag Memorial Hospital Presbyterian in Newport Beach, CA.

September 3, 2019

Previous Page

Page 52 of 438

Next Page